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Introduction
A pancreaticoduodenectomy (PD), also known as Whipple’s 
operation, is used for the surgical management of pancreatic 
head malignancies. It is characterised by removal of the pancreas 
head, duodenum, distal common bile duct, gallbladder and gastric 
antrum.1-3 Variations from the standard procedure are sometimes 
made which are necessitated by the tumour location and size. The 
most common variation is the preservation of the pylorus and gastric 
antrum, known as the pylorus-preserving pancreaticoduodenectomy 
(PPPD).1,2
Gastrointestinal continuity is re-established by various anastomoses 
to the remaining jejunum. Most commonly the remaining part of the 
stomach is anastomosed to the jejunum (gastrojejunostomy). The 
rest of the pancreas is anastomosed to the jejunum (pancreaticoje-
junostomy) and the bile duct to the jejunum (hepaticojejunostomy).1,2
The nutritional management of patients post surgery is dependent 
on the preoperative nutritional status, disease involvement and 
surgical procedure, i.e. resected areas and anastomoses made.
Case study
A 75-year old male was admitted to hospital on 30 July 2014 with 
a three-week history of jaundice, pruritus, pale stools and dark 
urine. He had a history of alcohol abuse, a stable angina and was on 
medication for hypertension.
The differential diagnoses of hepatitis or gallstones or cancer of the 
pancreas and gallbladder was made.
His anthropometric values on admission were:
• Weight: 53 kg. 
• Height: 170 cm.
• Usual body weight: 65 kg (i.e. 18% weight loss in less than six 
months).
His biochemical values on day 1 were as follows:
• A low serum albumin (25 g/l).
• Raised total bilirubin (206 µmol/l).
• Raised conjugated bilirubin (173 µmol/l).
• Raised gamma-glutamyl transferase (1 356 u/l)
• Raised alkaline phosphatase (1 127 u/l). 
During hospitalisation (preoperatively), he was placed on a full ward 
diet. On average, he consumed 60% of his food, and sometimes 
complained of vomiting after meals. He also presented with blood 
glucose values ranging from 6-16.8 mmol/l. 
After a computed tomography (CT) of the abdomen, the diagnosis of 
pancreas head carcinoma with obstructive jaundice was made. Aorta 
calcifications were also noted.
The patient was scheduled for surgery on 17 August and kept nil 
per mouth from the previous evening. Owing to another medical 
emergency, he could not go to theatre as planned, and only 
underwent a PD (standard Whipple’s operation) on 18 August 2014. 
Extensive unresectable spreading of the tumour was noted.
Postoperatively, he was admitted to the intensive care unit for 
monitoring. He was placed on free nasogastric (NG) drainage and 
received sips of water. On 19 August 2014, he was prescribed a 
diabetic fluid diet, but owing to abdominal distention and episodes of 
vomiting, this was not given. An insulin sliding scale was started, and 
he received between 12 and 20 units of short-acting insulin daily to 
control his blood glucose values.
Oral intake was initiated daily, but he was unable to consume 
more than one third of his fluid diet due to intermittent nausea and 
vomiting. By 23 August 2014, he was successfully tolerating his diet. 
It was decided to advance him to a full diabetic diet.
The following case study was discussed at the SASPEN Workshop held during the Nutrition Congress 2014. It is a reflection of the general 
opinion of the audience, followed by a rationale of the latest literature on the topic. Herewith follows a summarised discussion of the case.
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Question 1: Could you please comment on the nutritional 
status of the patient on admission, and on any contributing 
factors?
On admission, the patient had a body mass index of 18.3 kg/m2, 
indicating undernutrition. Significant weight loss of 18% in less than 
six months also supports this diagnosis. Contributing factors to the 
patient’s poor nutritional status could have been the presence of 
pancreas carcinoma, the poor dietary intake (as evidenced by the 
weight loss,) and a reported history of alcohol abuse.
Rationale
Preoperative nutritional status assessment can assist with early 
identification of patients with special nutritional needs. It is regarded as 
an important contributor to postoperative morbidity and mortality.2,4-6 
Certain components warrants special attention. Preoperative serum 
albumin values are highly regarded as a predictive prognostic 
variable postoperatively.2,4,6 A preoperative serum albumin of 
< 21 g/l is associated with 29% postoperative mortality and 30-day 
mortality of 65%.7 Jaundice due to tumour obstruction can indicate 
the extent of the damage.2 As always, anorexia and loss of appetite 
can contribute to weight loss, the extent and duration of which needs 
to be determined.2 Cancer cachexia is diagnosed if the weight loss is 
≥ 10% in six months.2,4 The combination of anorexia and weight loss 
≥ 10% is considered a poor prognostic sign.4
Pancreatic cancer is associated with malnutrition and cachexia.2,4 
Potential contributing mechanisms of cachexia include sustained 
proinflammatory cytokine response, catabolic effects of sepsis 
owing to increased energy expenditure, a poor dietary intake and 
early satiety, as well as gastrointestinal tract side-effects, e.g. 
vomiting, malabsorption and abdominal pain.2,4
Upon diagnosis, the majority of patients are already metastatic and 
the five-year survival rate are less than 5% in the case of extensive 
metastasis.1,8 Larger tumours also contribute to poor survival.
Surgery or chemotherapy, or a combination thereof, are the most 
common treatment options for pancreas cancer.1,3 The former can 
only be performed in cases of tumours that have not metastasised. 
Postoperative morbidity can be reduced by decreasing surgical 
stress, ensuring adequate pain control and early mobilisation, as 
well as the early introduction of nutrition.5 Alcohol abuse is also 
linked to twofold increased morbidity postoperatively. Similarly, 
daily cigarette smoking (> 2 cigarettes per day for one year) 
is known to increase postoperative complications. Hence, one 
month’s abstinence preoperatively is strongly recommended in 
alcohol abusers and smokers.5 Prolonged operating time, increased 
preoperative bilirubin, decreased preoperative albumin, advancing 
age and an advanced stage of cancer, are factors that are linked to 
increased postoperative mortality.1,4
Question 2: Do you agree with the preoperative fasting 
guidelines followed in this case?
No. The patient was kept nil per os for longer than 12 hours for the 
initial scheduled surgery, which had to be extended by another day. 
This is in contrast to the literature recommendations.
Rationale
Traditionally, overnight fasting is implemented before any surgical 
procedure. This is performed to decrease gastric content and the risk 
of pulmonary aspiration.5,9 However, evidence for the latter effect is 
slim.9
The latest recommendations state that the consumption of solids up 
to six hours, and clear fluids up two hours, before anaesthesia, does 
not increase gastric residual volume and is recommended before 
elective surgery. The intake of clear, carbohydrate-rich drinks results 
in enhanced glucose control postoperatively. Also, the patient is less 
anxious and presents with less hunger and thirst, and experiences 
accelerated recovery and a decreased risk of wound dehiscence.5,9-11
Preoperative carbohydrate-containing drinks should not be given to 
patients with diabetes mellitus until further information is obtained. 
However, the guidelines for solids still apply.5,9
Question 3: Postoperatively, the patient suffered from delayed 
gastric emptying. Could you speculate on the contributing 
factors, classify the delayed gastric emptying staging and 
indicate your treatment strategy?
The patient suffered from grade 1 delayed gastric emptying (DGE). 
The presence of uncontrolled blood glucose (diabetes mellitus), 
the consequences of Whipple’s operation (antral resection) and 
decreased motilin release (upper small bowel resection) were 
contributing factors to the DGE in this case.
Management include optimal glucose control, promotility drugs 
and medication to control the acid environment. An oral intake plus 
supplements should be tried as a first option to achieve optimal 
intake. Alternatively, enteral nutrition via the nasojejunal route using 
a semi-elemental or polymeric product should be investigated. 
The latter is only possible if a feeding tube is inserted during the 
operation.
Rationale
DGE is regarded as the most common complication post-Whipple’s 
operation. It affects from 10-60% of patients,1,2,3,5 and is the largest 
contributing factor to postoperative morbidity.1 Prominent symptoms 
include nausea, vomiting, bloating, early satiety and abdominal pain.3
As a result of DGE, oral intake is delayed. This affects the overall 
quality of life and lengthens hospital stay.1,2,8 It is recommended that 
promotility agents are prescribed to these patients.1,2
The most common causes for the development of DGE include 
diabetes mellitus; decreased motilin release, owing to small bowel 
resection; intra-abdominal complications and infections; the use of 
octreotide, i.e. somatostatin analogue; and surgical techniques, i.e. 
injury to the vagus nerve or pylorus muscle.1,2,8
Motilin is secreted by the duodenum and jejunum, and requires 
an alkaline medium for effective release. The main functions of 
motilin include controlling gastrointestinal motility by stimulating 
the gastric contractions and enhancing gastric emptying.1,2 It is also 
involved in the release of somatostatin, gall bladder contraction and 
94 2015;28(2)S Afr J Clin Nutr
SASPEN Case Study: Pancreas cancer with Whipple’s operation
the stimulation of endogenous release of the endocrine pancreas. 
Erythromycin and related antibiotics act as non-peptide motilin 
agonists, and are therefore sometimes used for their ability to 
stimulate gastrointestinal motility.1 Somatostatin slows down 
digestion, the muscle contractions of the gastrointestinal tract, 
blood flow to the intestines, and hence gastric emptying. Thus, the 
use of octreotide, a somatostatin analogue, could contribute to the 
development of DGE.1 
According to a recent systematic review, the risk factors most 
consistently and significantly associated with DGE were postoperative 
complications [odds ratio (OR) of 4.71], pancreatic fistula (OR of 
2.66) and preoperative diabetes (49% increased risk).8
The grading of DGE, as recommended by the International Study 
Group for Pancreatic Surgery, can be seen in Table I. The diagnosis 
and grading take into account the duration of NG tube placements, as 
well as the need for tube reinsertion, the duration of insufficient oral 
intake and presence of gastrointestinal side-effects. It is important 
to always eliminate the presence of any obstruction or stenosis. 2
Treatment options include:
• Prokinetic agents: Examples are erythromycin (a motilin receptor 
agonist)1,2 and metoclopramide2 (stimulates smooth muscle and 
increases gastric emptying). The antrum still needs to be present 
for optimal function with metoclopramide. 
• Proton-pump inhibitors: Proton-pump inhibitors (PPIs) decrease 
gastric secretions and result in a more alkaline environment.1
• Insulin therapy for optimal glucose control.1
Question 4: Please could you comment on the need for an 
insulin sliding scale to control blood glucose variations?
The extent of pancreatic damage due to cancer of the pancreas 
before surgery, linked to the partial pancreas resection, could result 
in diabetes mellitus owing to loss of endocrine function.
Rationale
Between 20% and 50% such patients develop diabetes mellitus after 
pancreatic resection. Blood glucose levels are raised immediately 
postoperatively due to stress and the use of certain medications.2,3 
This should resolve in many cases.1,2 However, up to 80% of 
individuals with pancreatic cancer have diabetes mellitus preceding 
the diagnosis. This is probably caused by long-term destruction of 
the pancreatic island tissue by the tumour.2
Treatment includes insulin therapy, preferably via constant infusion 
to manage blood glucose levels. Owing to reduced glucagon levels 
post surgery, patients are also prone to episodes of hypoglycaemia, 
and this should be managed by regular blood glucose monitoring.4,5
Question 5: Would you expect this patient to suffer from 
malabsorption postoperatively? If “yes”, how would you 
manage it?
Yes. The extent of the pancreatic damage due to the cancer of the 
pancreas before surgery, linked to the partial pancreas resection, 
could also result in malabsorption due to loss of exocrine function.
Management includes a low-fat intake (the amount is determined 
by the patient’s tolerance), small frequent meals, oral nutrition 
supplements to ensure optimal intake, and pancreatic enzymes 
replacement, i.e the amount determined by fat malabsorption.
Rationale
The majority (68-92%) of patients with cancer of the pancreas suffer 
from exocrine pancreatic insufficiency (EPI).1,2 This may continue 
postoperatively.1 A decreased secretion of bicarbonate by the ailing 
pancreas results in an acidic environment which denatures the 
available digestive enzymes. This contributes to insufficient exocrine 
function.1
The consequences of EPI include diarrhoea, steatorrhoea (> 90% 
resected or long-standing pancreatitis), micronutrient deficiencies 
and weight loss.2,6 Cancer of the pancreas is also associated with 
the highest levels of malnutrition. 2
A 72-hour faecal fat test (100 g fat intake) needs to be performed for 
a diagnosis of EPI to be made. A positive test is reported if > 7% of 
the total amount of fat consumed is present in the stool.1
Treatment options include reduced dietary fat intake, individualised 
according to tolerance, and the use of pancreatic enzymes.1-3 
Although most pancreatic enzymes are enteric coated (except for 
Viokase®), it is still recommended that PPIs are also administered 
to neutralise the environment because an acid environment can 
inactivate the pancreatic enzymes.1,2 
Pancreatic enzymes can be administered via a jejunal feeding tube 
provided the capsule is opened and the content is mixed with water 
and bicarbonate. After leaving the mixture for 15-20 minutes, it can be 
flushed down the tube or mixed with the formula.1 The recommended 
dosage is 2 000-4 000 units of lipase/gram fat or 25 000-40 000 
units per meal to a maximum of 10 000 units/kg/day.1
Table I: The grading of delayed gastric emptying1,2
Grade A Grade B Grade C
Nasogastric tube required 4-7 days or
reinserted > postoperative day 3
8-14 days or
reinserted > postoperative day 7
> 14 days or
re-inserted > postoperative day 14
Unable to tolerate solid oral intake by 
postoperative day
7 14 21
Vomiting or gastric distention No/yes Yes Yes
Use of nutrition support No Required for first 3 weeks 
postoperatively
Required for more than 3 weeks
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Question 6: Could you please comment on the nutritional 
management of this patient?
Oral intake should always be used initially, as was implemented in 
this case. This can be accompanied by oral nutritional supplements 
if the intake is insufficient. If the combination approach still does not 
meet the patient’s needs, enteral tube feeding (nasojenunal) should 
be initiated.
Rationale
The main goal of nutritional management in a patient with cancer 
of the pancreas is to alleviate the effects of cancer cachexia.4 An 
individualised approach should be followed so that any specific 
complications that may arise post surgery can be taken into 
consideration.
The use of the enteral versus parenteral route has been debated 
extensively. As always, the principle of “if the gut works, use it” 
should be the first approach. 
Early postoperative enteral feeding should be aimed for, as 
appropriate.4 The advantages and disadvantages of early enteral 
feeding are summarised in Table II. The placement of a feeding tube 
distal to the anastomoses areas (nasojejunal or jejunostomy tube) is 
ideal.4 Cyclic feeding seems to be the recommended administration 
method because it results in less postoperative gastric stasis.4
Table II: The consequences of early enteral feeding4,12,13
Advantages Disadvantages
Enhances the immune function Diarrhoea
Decreases infection rates Abdominal cramping
Maintains gut integrity Excess gas production
Promotes wound healing Delayed gastric emptying
Results in less complications Dislocation or blockage of the tube
Is associated with decreased costs Intra-abdominal leakage
Is a quicker transition to oral intake 
(versus parenteral nutrition)
Small bowel necrosis
The consequence of DGE owing to early enteral feeding was refuted 
in a recent systematic review which found no significant effect in 
the development of DGE between patients receiving early enteral 
feeding and those who did not (OR of 1.05).8
The use of immunonutrition for 5-7 days perioperatively,1,4,5 and 
seven days postoperatively,4 should be considered because it 
may reduce the prevalence of infectious complications in patients 
undergoing major open abdominal surgery. 
Oral intake in the form of clear fluids can be initiated as soon as 
possible in such cases where the NG tube has been removed.1 
However, debate exists about the implementation of a clear fluid 
diet versus allowing the patient to choose which foods he or she 
prefers. Provided that patients are informed about the potential of 
impaired gut function in the early postoperative period and advised 
on management thereof, the latter option results in improved patient 
satisfaction and an earlier attainment of nutritional needs.1,5 Oral 
nutrition supplements, in combination with oral food intake, are an 
attractive alternative to the use of enteral nutrition.4 Ensuring that 
the nutritional goals are met and individualising the prescription of a 
given patient should remain the main priority.
The routine use of parenteral nutrition (PN) as a sole source of nutrition 
is not recommended, and this option should only be applied when the 
oral and enteral routes have been unsuccessful.4 The combination 
of early enteral nutrition with PN is thought to be superior to PN 
alone, as found in a recent study which showed decreased infectious 
complications, a shorter hospital stay, improved nutritional status 
and improved glucose control in the group receiving the combination 
therapy.12
A recent systematic review assessed the outcomes of the different 
feeding strategies post PD. No major differences in outcome were 
found between the oral, enteral and parenteral feeding routes. Since 
the oral route was not inferior to, and in some cases resulted in 
better outcomes, than the enteral or parenteral route, oral feeding 
should be considered as the preferred route after PD.14
Summarising the section on nutritional management
According to the Enhanced Recovery after Surgery Society practice 
guidelines for PD, the routine use of preoperative artificial nutrition 
is not warranted, but significantly malnourished patients should be 
optimised with oral supplements or enteral nutrition preoperatively. 
Postoperatively, patients should be permitted a normal diet after 
surgery without restrictions. They should be cautioned to begin 
carefully and to increase intake according to tolerance over 3-4 
days. Enteral tube feeding should be given only according to 
specific indications, and parenteral nutrition should not be employed 
routinely.5 
Discussion
DGE, a pancreatic fistula, diabetes mellitus or glucose intolerance, 
malabsorption and vitamin and mineral deficiencies are the most 
common complications encountered post Whipple’s operation.1-3
The patient discussed in this case study suffered from three of 
these complications. For the sake of completeness, the other two 
complications will be discussed briefly.
Pancreatic fistula 
Pancreatic fistulas develop in 12-38% of patients postoperatively.1,2 
Well-known risk factors for this complication include being of an age 
> 65 years, being male, a BMI > 23 kg/m2, a short main pancreatic 
duct (< 3 mm), the presence of other co-morbidities, raised 
preoperative C-reactive protein values, malnutrition and delayed 
enteral feeding postoperatively.1
The diagnosis of a fistula, as defined by the International Study 
Group for Pancreatic Fistulas (ISGFP) is made in the presence of an 
output via a drain of any fluid on or after postoperative day 3, and 
when the amylase content of the fluid is greater than three times 
the upper normal serum value.1,2 The ISGFP has defined a grading 
classification for pancreatic fistulas (Table III).
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Table III: The grading of pancreatic fistulas1
Grade A Grade B Grade C
Sign of infection No Yes Yes
Sepsis No No Yes
Evidenced by a CT 
scan or ultrasound
No Possibly Yes
Reoperation required No No Possibly
Nutritional intervention None specific Possibly NPO 
with EN/PN
Definitely NPO 
with EN/PN
CT: computed tomography, NPO: nil per os, EN: enteral nutrition, PN: parenteral nutrition
The treatment includes octreotide, a somatostatin analogue, which 
inhibits pancreatic secretions,1,2 enteral access distal to the pancreas 
or PN in the case of a high-output fistula. The use of somatostatin 
analogues are not recommended as the primary treatment option 
by the European Society for Clinical Nutrition and Metabolism5 since 
they do not produce consistent benefits on outcome. A general 
description of the management of fistulas was provided in a recent 
case study discussion.15
Vitamin and mineral deficiencies
The duodenum and proximal jejunum are important sites for the 
absorption of iron, folate, fatty acid, protein and trace elements. 
Surgical resections which result these parts of the small bowel 
being bypassed could result in impaired absorption of iron, calcium, 
zinc, copper, selenium and fat-soluble vitamins.1-3 In addition, the 
occurrence of small intestine bacterial overgrowth, as a result of 
gastric stasis and the decreased release of gastric acid, is found 
in up to 40% of patients with pancreas insufficiency. Deficiency 
of vitamin B12 and folate is common during the presence of small 
intestine bacterial overgrowth.1,3
Conclusion
Significant factors are associated with the high rate of mortality in 
patients with pancreatic cancer. These include the advanced stage 
of the disease by the time of diagnosis, the inherent aggressive 
biology of pancreatic adenocarcinoma and a poor nutritional status. 
The surgical procedure dictates the postoperative complications 
and management to a large extent. An individualised approach in 
treating complications and in selecting the most appropriate route of 
nutrition support is advocated.
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